Search

everythinglearnresearchcommunity

for

Search:↓

Hair transplantation between identical twins can successfully treat severe, nonprogressive hair loss due to follicular aplasia.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Personalized treatment plans improve vitiligo care.

Damaged hair follicle stem cells can cause permanent hair loss, but understanding their role could lead to new treatments.

Blocking the NOTCH pathway can prevent fibrosis in systemic sclerosis.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

Too much or too little selenium in the diet can cause hair loss and graying in mice.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Injecting certain cells into mice caused hair loss, which was preventable with a specific inhibitor.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Hair transplantation can lead to rare scalp complications, requiring careful follow-up and treatment.

Trichoscopy and trichogram are useful for diagnosing hair and scalp conditions.

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

Minoxidil 2% is more effective than tacrolimus 0.1% for hair regrowth in mild to moderate patchy hair loss, and combining both might give better results.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

The protein aPKCλ is crucial for keeping hair follicle stem cells inactive and for hair growth and regeneration.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Etretinate has only moderate effects on localized scleroderma and lichen sclerosus.